CRP and COVID-19: Zhong Nanshan's team reported in the literature that 63.4% of COVID-19 patients had a fever and lung abnormalities in chest CT scans; experimental studies have shown that patients with COVID-19 have lymphocyte reduction and increased levels of reactive protein (CRP) [7].